Finance

Beta
Lists
301602:SHE
Shantou Institu of Ultrsnc Instrn Co Ltd
CNÂ¥15.46
+6.84%
(+0.99) 1D
Jul 16, 3:04:49 PM GMT+8  ·   CNY
All symbols
SymbolPriceChange% Change
Generating top insights for 301602...
Open
CNÂ¥14.41
High
CNÂ¥15.75
Low
CNÂ¥14.41
Mkt. cap
6.20B
Avg. vol.
2.60M
Volume
7.95M
Dividend
0.97%
Quarterly dividend
CNÂ¥0.04
Ex-dividend date
Jun 24, 2026
P/E ratio
55.78
52-wk high
CNÂ¥29.48
52-wk low
CNÂ¥13.40
EPS
CNÂ¥0.28
Shares outstanding
428.33M
No. of employees
737
Open
CNÂ¥14.41
High
CNÂ¥15.75
Low
CNÂ¥14.41
Mkt. cap
6.20B
Avg. vol.
2.60M
Volume
7.95M
Dividend
0.97%
Quarterly dividend
CNÂ¥0.04
Ex-dividend date
Jun 24, 2026
P/E ratio
55.78
52-wk high
CNÂ¥29.48
52-wk low
CNÂ¥13.40
EPS
CNÂ¥0.28
Shares outstanding
428.33M
No. of employees
737
News stories
From sources across the web
Profile
Shantou Institute of Ultrasonic Instruments Co., Ltd is China's biggest manufacturing base of ultrasound with longest history. SIUI goes through a technology development of A-B-C-D-E. Each step has driven the industry progress in China. A: A mode ultrasound equipment. B:B mode ultrasound imaging equipment. C:Color Doppler. In 1997, SIUI manufactured its first color Doppler system Apogee 800.D:Real-time 3D/4D ultrasound. In 2008, SIUI developed the real-time 3D/4D technology, and released a series of real-time 3D/ 4D color Doppler systems. E: Elastography. SIUI develops and manufactures a variety of ultrasound imaging systems and accessories for both human and veterinary use, and NDT equipment including phased-array ultrasonic flaw detector, conventional flaw detector, thickness gauge, probes and accessories. The company is currently organized into three product category divisions: ultrasound imaging systems, medical X-Ray imaging products, and non-destructive testing instruments. SIUI has been certified by ISO9001 Certification, European CE Marking and the U.S. Food and Drug Administration. Wikipedia
About Shantou Institu of Ultrsnc Instrn Co Ltd
CEO-
Employees737
FoundedNov 15, 1982
Headquarters-
SectorMedical device
Previous reportsAll values in CNY
Loading Previous Earnings...
Income statement
Revenue
Net income
All values in CNY
Jun 2025
Sep 2025
Dec 2025
Mar 2026
Revenue
85.25M
69.93M
151.90M
66.33M
Cost of goods sold
22.11M
20.10M
49.56M
20.19M
Cost of revenue
22.11M
20.10M
49.56M
20.19M
Research and development expenses
13.58M
14.30M
10.79M
10.32M
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
23.89M
20.23M
27.28M
21.73M
Operating expense
36.64M
26.42M
45.18M
32.21M
Total operating expenses
58.75M
46.52M
94.74M
52.40M
Operating income
26.50M
23.41M
57.17M
13.92M
Other non operating income
706.27K
-7.18M
7.11M
-10.06M
EBT including unusual items
32.42M
22.85M
69.99M
10.16M
EBT excluding unusual items
33.76M
26.59M
59.23M
10.08M
Income tax expense
3.29M
2.35M
10.01M
1.04M
Effective tax rate
10.16%
10.30%
14.30%
10.28%
Other operating expenses
440.13K
-8.09M
6.04M
167.40K
Net income
29.12M
20.50M
59.98M
9.11M
Net profit margin
34.16%
29.31%
39.48%
13.74%
Earnings per share
-
-
-
-
Interest and investment income
9.13M
7.79M
8.23M
6.22M
Interest expense
-
-
-
-
Net interest expenses
9.13M
7.79M
8.23M
6.22M
Depreciation and amortization charges
-
-
-
-
EBITDA
29.28M
26.00M
60.00M
16.76M
Gain or loss from assets sale
-
-
-
-
AI content may include mistakes. Learn more

Research

What's on your mind?
What's going on with the markets today?
Explore what’s possible
Create a portfolio
Create a task
Deep Search
AI content may include mistakes. Learn more